Evidence map›Paper›PMID 26024522›Full record

ArticlePLoS pathogens2015

Evidence for a Novel Mechanism of Influenza Virus-Induced Type I Interferon Expression by a Defective RNA-Encoded Protein.

Yvonne Boergeling, Timofey S Rozhdestvensky, Mirco Schmolke, Patricia Resa-Infante, Thomas Robeck, Gerrit Randau, Thorsten Wolff, Gülsah Gabriel, Jürgen Brosius, Stephan Ludwig

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 2 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 2 syntheses or guidelines pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Journal of virology · 2022
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Cardiac glycosides decrease influenza virus replication by inhibiting cell protein translational machinery.American journal of physiology. Lung cellular and molecular physiology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Yvonne BoergelingInstitute of Molecular Virology (IMV), Center for Molecular Biology of Inflammation (ZMBE), University of Muenster, Muenster, Germany.
Timofey S RozhdestvenskyInstitute of Experimental Pathology, Center for Molecular Biology of Inflammation (ZMBE), University of Muenster, Muenster, Germany.
Mirco SchmolkeInstitute of Molecular Virology (IMV), Center for Molecular Biology of Inflammation (ZMBE), University of Muenster, Muenster, Germany.
Patricia Resa-InfanteViral Zoonosis and Adaptation, Heinrich-Pette-Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany.
Thomas RobeckInstitute of Experimental Pathology, Center for Molecular Biology of Inflammation (ZMBE), University of Muenster, Muenster, Germany.
Gerrit RandauInstitute of Experimental Pathology, Center for Molecular Biology of Inflammation (ZMBE), University of Muenster, Muenster, Germany.
Thorsten WolffDivision of Influenza Viruses and Other Respiratory Viruses, Robert Koch Institute, Berlin, Germany.
Gülsah GabrielViral Zoonosis and Adaptation, Heinrich-Pette-Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany.
Jürgen BrosiusInstitute of Experimental Pathology, Center for Molecular Biology of Inflammation (ZMBE), University of Muenster, Muenster, Germany; Institute of Evolutionary and Medical Genomics, Brandenburg Medical School (MHB), Neuruppin, Germany.
Stephan LudwigInstitute of Molecular Virology (IMV), Center for Molecular Biology of Inflammation (ZMBE), University of Muenster, Muenster, Germany; Interdisciplinary Center of Clinical Research (IZKF), Medical Faculty, University of Muenster, Muenster, Germany; Cells-in-Motion Cluster of Excellence, University of Muenster, Muenster, Germany.
Institute of Molecular Biology · DELeibniz Institute of Virology (LIV) · DEMedizinische Hochschule Brandenburg Theodor Fontane · DERobert Koch Institute · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Influenza A virus (IAV) defective RNAs are generated as byproducts of error-prone viral RNA replication. They are commonly derived from the larger segments of the viral genome and harbor deletions of various sizes resulting in the generation of replication incompatible viral particles. Furthermore, small subgenomic RNAs are known to be strong inducers of pattern recognition receptor RIG-I-dependent type I interferon (IFN) responses. The present study identifies a novel IAV-induced defective RNA derived from the PB2 segment of A/Thailand/1(KAN-1)/2004 (H5N1). It encodes a 10 kDa protein (PB2∆) sharing the N-terminal amino acid sequence of the parental PB2 protein followed by frame shift after internal deletion. PB2∆ induces the expression of IFNβ and IFN-stimulated genes by direct interaction with the cellular adapter protein MAVS, thereby reducing viral replication of IFN-sensitive viruses such as IAV or vesicular stomatitis virus. This induction of IFN is completely independent of the defective RNA itself that usually serves as pathogen-associated pattern and thus does not require the cytoplasmic sensor RIG-I. These data suggest that not only defective RNAs, but also some defective RNA-encoded proteins can act immunostimulatory. In this particular case, the KAN-1-induced defective RNA-encoded protein PB2∆ enhances the overwhelming immune response characteristic for highly pathogenic H5N1 viruses, leading to a more severe phenotype in vivo.

Indexed as

AnimalsBlotting, NorthernBlotting, WesternHemagglutination TestsImmunoprecipitationInfluenza A virusInterferon Type IMiceMice, Inbred BALB COrthomyxoviridae InfectionsReal-Time Polymerase Chain ReactionReverse Transcriptase Polymerase Chain ReactionRNA-Dependent RNA PolymeraseRNA, MessengerRNA, ViralSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationInterferon Type IPB2 protein, Influenzavirus ARNA-Dependent RNA PolymeraseRNA, MessengerRNA, ViralViral Proteins

Identifiers

PMID26024522
PMCPMC4449196
OpenAlexW2107331833

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.